CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Total Equity of Capri	Total Equity of Capri Cumulative Effect, Period of Adoption, Adjustment	Total Equity of Capri Cumulative Effect, Period of Adoption, Adjusted Balance	Ordinary Shares	Ordinary Shares Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Treasury Shares	Treasury Shares Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Non-controlling Interests	Non-controlling Interests Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Mar. 31, 2018							210,991,000
Beginning balance at Mar. 31, 2018	$ 2,034			$ 2,030			$ 0		$ 831		$ (3,016)		$ 51		$ 4,164			$ 4
Beginning balance, treasury (in shares) at Mar. 31, 2018											(61,293,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	542			543											543			(1)
Other comprehensive income (loss)	(117)			(117)									(117)					0
Comprehensive (loss) income	425			426														(1)
Issuance of ordinary shares (in shares)							2,395,000
Issuance of ordinary shares	91			91					91
Vesting of restricted awards, net of forfeitures (in shares)							818,000
Exercise of employee share options (in shares)							1,847,000
Exercise of employee share options	29			29					29
Share based compensation expense	60			60					60
Repurchase of common stock (in shares)											(3,826,000)
Repurchase of common stock	(207)			(207)							$ (207)
Ending balance (in shares) at Mar. 30, 2019							216,051,000
Ending balance at Mar. 30, 2019	2,432	$ (152)	$ 2,280	2,429	$ (152)	$ 2,277	$ 0	$ 0	1,011	$ 1,011	$ (3,223)	$ (3,223)	(66)	$ (66)	4,707	$ (152)	$ 4,555	3	$ 3
Ending balance, treasury (in shares) at Mar. 30, 2019											(65,119,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(225)			(223)														(2)
Other comprehensive income (loss)	141			141									141					0
Comprehensive (loss) income	(84)			(82)														(2)
Vesting of restricted awards, net of forfeitures (in shares)							1,262,000
Exercise of employee share options (in shares)							7,000
Exercise of employee share options	0
Share based compensation expense	70			70					70
Repurchase of common stock (in shares)											(2,775,000)
Repurchase of common stock	(102)			(102)							$ (102)
Adjustment of redeemable non-controlling interests to redemption value	$ 4			4					4
Ending balance (in shares) at Mar. 28, 2020	217,320,010						217,320,000
Ending balance at Mar. 28, 2020	$ 2,168			2,167			$ 0		1,085		$ (3,325)		75		4,332			1
Ending balance, treasury (in shares) at Mar. 28, 2020	(67,894,398)										(67,894,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (63)			(62)											(62)			(1)
Other comprehensive income (loss)	(19)			(19)									(19)					0
Comprehensive (loss) income	(82)			(81)														(1)
Vesting of restricted awards, net of forfeitures (in shares)							1,456,000
Exercise of employee share options (in shares)							447,000
Exercise of employee share options	3			3					3
Share based compensation expense	70			70					70
Repurchase of common stock (in shares)											(49,000)
Repurchase of common stock	(1)			(1)							$ (1)
Other	$ (1)																	(1)
Ending balance (in shares) at Mar. 27, 2021	219,222,937						219,223,000
Ending balance at Mar. 27, 2021	$ 2,157			$ 2,158			$ 0		$ 1,158		$ (3,326)		$ 56		$ 4,270			$ (1)
Ending balance, treasury (in shares) at Mar. 27, 2021	(67,942,926)										(67,943,000)